Eads & Heald Wealth Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Eads & Heald Wealth Management's ELV Position: Q1 2026 in Review
Eads & Heald Wealth Management reduced its Elevance Health (ELV) stake by 1.9% in Q1 2026, selling an estimated $9.2K and leaving 1,480 shares worth $433K. The position accounts for 0.22% of the portfolio, ranked #119.
Eads & Heald Wealth Management first reported a position in ELV in Q2 2025 and has held it in 4 quarters since. The position peaked at $529K in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Eads & Heald Wealth Management held 1,480 shares of Elevance Health worth $433K as of Q1 2026.
- Eads & Heald Wealth Management sold 28 Elevance Health shares in Q1 2026, an estimated $9.2K.
- Elevance Health made up 0.22% of Eads & Heald Wealth Management's portfolio in Q1 2026, its #119 holding.
- Eads & Heald Wealth Management first reported a position in Elevance Health in Q2 2025 and has held it in 4 quarters since.
- Eads & Heald Wealth Management's Elevance Health position peaked at $529K in Q4 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Eads & Heald Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.